REDEFINING ALZHEIMER’S DISEASE THROUGH MODERN BIOTECHNOLOGY; FROM MOLECULAR PATHOGENESIS TO INNOVATIVE THERAPEUTICS AND DIAGNOSTIC FRONTIERS. Journal of Medical & Health Sciences Review, [S. l.], v. 2, n. 4, 2025. DOI: 10.65035/w1y9ey43. Disponível em: https://jmhsr.info/index.php/jmhsr/article/view/1030. Acesso em: 23 mar. 2026.